These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2264065)

  • 21. New techniques in antivenom production and active immunization against snake venoms.
    Theakston RD
    Trans R Soc Trop Med Hyg; 1989; 83(4):433-5. PubMed ID: 2694474
    [No Abstract]   [Full Text] [Related]  

  • 22. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa.
    Gutiérrez JM; Rojas E; Quesada L; León G; Núñez J; Laing GD; Sasa M; Renjifo JM; Nasidi A; Warrell DA; Theakston RD; Rojas G
    Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):468-75. PubMed ID: 15837359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological studies on polyvalent and monovalent snake antivenins.
    Mohamed AH; Khalil FK; Baset AA
    Toxicon; 1977; 15(4):271-5. PubMed ID: 407671
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of immunoturbidimetry to detect venom-antivenom binding using snake venoms.
    O'Leary MA; Maduwage K; Isbister GK
    J Pharmacol Toxicol Methods; 2013; 67(3):177-81. PubMed ID: 23416032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross reactivity of mono- and polyvalent antivenoms with Viperidae and Crotalidae snake venoms.
    Kornalík F; Táborská E
    Toxicon; 1989; 27(10):1135-42. PubMed ID: 2815109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of antivenoms in the treatment of snake envenomation].
    Chippaux JP
    Bull Acad Natl Med; 2013; 197(4-5):993-1006; discussion 1006-8. PubMed ID: 25518165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the potency of three Brazilian Bothrops antivenoms using in vivo rodent and in vitro assays. BIASG (Butantan Institute Antivenom Study Group).
    Laing GD; Theakston RD; Leite RP; da Silva WD; Warrell DA
    Toxicon; 1992 Oct; 30(10):1219-25. PubMed ID: 1440628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The production and characteristics of a coral snake (Micrurus mipartitus Hertwigi) antivenin.
    Bolaños R; Cerdas L; Taylor R
    Toxicon; 1975 Mar; 13(2):139-42. PubMed ID: 1129821
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on the method of determining the effect of antimyonecrotic factor antibody in Habu-antivenin [proceedings].
    Chinzei H
    Jpn J Med Sci Biol; 1978 Apr; 31(2):204-5. PubMed ID: 682381
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of protective B-cell epitopes of Atroxlysin-I: A metalloproteinase from Bothrops atrox snake venom.
    Schneider FS; de Almeida Lima S; Reis de Ávila G; Castro KL; Guerra-Duarte C; Sanchez EF; Nguyen C; Granier C; Molina F; Chávez-Olortegui C
    Vaccine; 2016 Mar; 34(14):1680-7. PubMed ID: 26917009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on Egyptian Cerastes cerastes antivenin.
    Mohamed AH; Darwish MA; Hani-Ayobe M
    Toxicon; 1974 Dec; 12(6):599-601. PubMed ID: 4218382
    [No Abstract]   [Full Text] [Related]  

  • 32. A Heterologous Multiepitope DNA Prime/Recombinant Protein Boost Immunisation Strategy for the Development of an Antiserum against Micrurus corallinus (Coral Snake) Venom.
    Ramos HR; Junqueira-de-Azevedo Ide L; Novo JB; Castro K; Duarte CG; Machado-de-Ávila RA; Chavez-Olortegui C; Ho PL
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004484. PubMed ID: 26938217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological studies on monovalent Enhydrina schistosa antivenin.
    Gawade SP; Gaitonde BB
    Indian J Med Res; 1980 Dec; 72():895-900. PubMed ID: 7228199
    [No Abstract]   [Full Text] [Related]  

  • 34. Categorization of venoms according to bonding properties: An immunological overview.
    Ibrahim NM; El-Kady EM; Asker MS
    Mol Immunol; 2016 Feb; 70():24-33. PubMed ID: 26690707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations.
    León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM
    Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development of IgY(DeltaFc) antibody based neuro toxin antivenoms and the study on their neutralization efficacies.
    Chiou VY
    Clin Toxicol (Phila); 2008 Jul; 46(6):539-44. PubMed ID: 18584367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Exotic snake bites in Switzerland].
    Stadelmann M; Ionescu M; Chilcott M; Berney JL; Gétaz L
    Rev Med Suisse; 2010 May; 6(248):969-72. PubMed ID: 20545262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgG subclass distributions of anti-horse serum antibodies and natural venom-antibodies produced in response to antivenom injection or snake bite in humans.
    Ameno S; Ameno K; Fuke C; Kiryu T; Ijiri I
    Toxicon; 1990; 28(3):347-50. PubMed ID: 2343468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
    Gutiérrez JM; Lomonte B; León G; Alape-Girón A; Flores-Díaz M; Sanz L; Angulo Y; Calvete JJ
    J Proteomics; 2009 Mar; 72(2):165-82. PubMed ID: 19344652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of passive haemagglutination (PHA) and haemagglutination inhibition (HAI) technique for potency estimation of Cobra Antisnake Venom Serum (ASVS).
    Pradhan S; Kumar S; Singh D; Sood RC; Sehgal R
    Biologicals; 2007 Jun; 35(3):155-60. PubMed ID: 17088076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.